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Introduction
 Nasopharyngeal carcinoma (NPC) is a disease with 
distinct ethnic and geographic distribution as compare 
to other head and neck cancer (Jemal et al., 2010). 
The majority of newly diagnosed NPC patients have 
loco-regionally advanced disease (Abbasi et al., 2011). 
Traditionally Nasopharyngeal carcinoma has been treated 
with definitive chemo-radiotherapy due to its unique 
location (Baujat et al., 2006). Very little help is available 
from surgical side in its management except salvage neck 
dissection or biopsy (Chen et al., 2012). The basic aim 
of treatment is to deliver a curative dose of radiotherapy 
to the tumor without damaging the surrounding normal 
structures. To achieve or target this aim put the radiation 
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Abstract
 Background: Radiation therapy is the mainstay of treatment for nasopharyngeal carcinoma. Importance 
of tumor coverage and challenges posed by its unique and critical location are well evident. Therefore we 
aimed to evaluate our radiation treatment plan through dose volume histograms (DVHs) to find planning 
target volume (PTV) dose coverage and factors affecting it. Materials and Methods: This retrospective study 
covered 45 histologically proven nasopharyngeal cancer patients who were treated with definitive 3D-CRT and 
chemotherapy between Feb 2006 to March 2013 at the Department of Oncology, Section Radiation Oncology ,Aga 
Khan University Hospital, Karachi, Pakistan. DVH was evaluated to find numbers of shrinking field (phases), 
PTV volume in different phases and its coverage by the 95% isodose lines, along with influencing factors. 
Results: There were 36 males (80%) and 9 females (20%) in the age range of 12-84 years. Stage IVA (46.7%) 
was the most common stage followed by stage III (31.1). Eighty six point six-percent received induction, 95.5% 
received concurrent and 22.2% received adjuvant chemotherapy. The prescribed median radiation dose was 
70Gy to primary, 60Gy to clinically positive neck nodes and 50Gy to clinically negative neck regions. Mean dose 
to spinal cord was 44.2Gy and to optic chiasma was 52Gy. Thirty seven point eight-percent patients completed 
their treatment in three phases while 62.2% required four to five phases. Mean volume for PTV3 was 247.8 cm3 
(50-644.3), PTV4 173.8 cm3 (26.5-345.1) and PTV5 119.6 cm3 (18.9-246.1) and PTV volume coverage by 95% 
isodose lines were 74.4%, 85.7% and 100% respectively. Advanced T stage, intracranial extension and tumor 
volume >200 cm3 were found to be important factors associated with decreased PTV coverage by 95% isodose line. 
Conclusions: 3D CRT results in adequate PTV dose coverage by 95% isodose line. However advanced T stage, 
intracranial extension and large target volume require more advanced techniques like IMRT for appropriate 
PTV coverage. 
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oncologist into very challenging situation due to its 
strategic location and proximity to normal critical structure 
like brain stem, visual apparatus and spinal cord. Moreover 
this issue is complicated by the fact that the radiation 
dose required to eradicate tumor from nasopharynx are 
far more than what is considered to be the tolerance limit 
of surrounding normal structures (Liu et al., 2003). To 
address these challenges 2 dimensional radiotherapy 
techniques, that has been used traditionally, was replaced 
by three dimensional conformal radiotherapy (3DCRT) 
(Teo et al., 2004). CT scan based planning provides better 
delineation of tumor target and organ at risk with clearer 
radiologic visualization of their spatial relation, more 
optimization of beam orientation, beam weighting and 
beam shaping through beam eye view application (BEV) 
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thus improving the therapeutic index. It represents a major 
step forward in modern treatment planning. However the 
problem of dose inhomogenity and suboptimal coverage 
is still unresolved because of highly infiltrative growth 
pattern with a propensity to spread through skull base 
foramina to the intracranial structures particularly visual 
apparatus as well as parapharyngeal space and large 
neck lymph nodes, in addition, there is a variation of the 
anatomic structure of the nasopharynx between individuals 
(Kam et al., 2003). This has led the radiation oncologist 
to break the treatment plan into different phases that has 
also compromised tumor coverage. Importance of tumor 
volume also emphasized by the recent studies that shows 
tumor volume to be important prognostic factor in term 
of local control and diseases free survival therefore good 
tumor coverage according to the international commission 
on radiation units and measurement (ICRU) report 50 
recommendation, got further importance (Sarisahin et 
al., 2010). By taking into consideration all these facts we 
conducted a study that retrospectively evaluate the PTV 
coverage by the three dimensional conformal radiotherapy 
at a single institution. Since failure at the primary site is 
the major fear due to limited surgical or other treatment 
support as compared to the nodal site, secondly coverage 
of the nodal area required electron beam therapy as well 
and its contribution in the dose coverage is not evaluated 
through dose volume histogram in our present planning 
system therefore we focus on the treatment plans for the 
primary tumor target volume only in the our study. Results 
obtained are compared with recent literature.
Materials and Methods
Patient cohort
 A retrospective review was conducted on case records 
of all NPC patients treated at Department of Oncology 
section Radiation Oncology Aga Khan University Hospital 
Karachi Pakistan with three dimensional conformal 
radiotherapy from February 2006 to March 2013. We 
included all patients with newly diagnosed, non metastatic 
histologically proven diseases who were fit enough to 
tolerate a course of definitive chemo-radiotherapy.
 All patients were staged by a standard protocol 
comprising physical  examination,  f iber-optic 
nasopharynogoscopy, chest radiograph, liver ultrasound 
and a radionuclide bone scan was done where indicated. 
CT scan head and neck was done in all patients along with 
MRI Head in patients who were found to have intracranial 
extension. All patients were staged according to the 
international Union Against Cancer (UICC)/American 
Joint Committee on Cancer (AJCC) 2009 staging system.
Radiation treatment
 All patients underwent simulation after immobilization 
in supine position with a thermoplastic mask. Area of 
interest defined and parameters were taken after which 
CT scan was performed with IV contrast using 3-5mm 
slices from the head to the level of 2cm below the 
sternoclavicular joint sometimes up to the level of carina 
in patients who had enlarged Supraclavicular lymph nodes. 
The images were transferred to the treatment planning 
system Varian eclipse for tumor marking and planning. 
The planning target volume was marked according to 
the international Commission on Radiation Units and 
Measurement (ICRU) report 50 and 62. The gross tumor 
was marked based on the pre-chemotherapy scan in 
patients who received neo-adjuvant chemotherapy; a 
margin of 15-20 mm was added to make it clinical target 
volume (CTV) and finally 3-5 mm margin to make it 
planning target volume (PTV). Typically a radiation dose 
of 70Gy was delivered to the primary target volume with 
curative intent, 60-66Gy to all grossly involved lymph 
nodes and a minimum of 50Gy to all nodal region that were 
at risk of harboring microscopic diseases. Treatment was 
given in once daily fraction @2Gy per fraction five days 
a week except in one patient who got radiation @2.2Gy 
per fraction due to the treatment interruption. Dose was 
prescribed at 100% isodose line. A dose variation of +7 
to -5% was accepted according to the ICRU report 50 
recommendation. Dose was calculated using eclipse 
software with full 3D compensation and heterogeneity 
corrections. Patients were treated with 6MV photon beam 
initially followed by an 18MV photon boost to the primary. 
The treatment was delivered by Varian linear accelerator 
2100C with 120 multileaf collimators. During treatment 
portal images conventional or electronic were obtained 
and compared with planning images for verification.
 As already discussed in the introduction that 
radiotherapy dose required to cure the NPC cancer is 
greater than the tolerance of surrounding normal structure 
therefore treatment is divided into phases. Typically in 
phase 1 lateral parallel opposed field approach were used 
that extend 1cm superior to the cranial extent of NPC 
tumor to the as low as reasonably possible by keeping 
the fact of shoulder clearance in lateral fields. It includes 
primary tumor and the cervical nodes up to 40Gy along 
with shielding for posterior cranial fossa, oral cavity and 
eyes. In phase 2 the posterior border of lateral fields moved 
anteriorly to shield the spinal cord and delivered the dose 
up to 50Gy with electrons beam. In Phase 3 field shaping 
was done by keeping two things in mind first status 
of the lymph nodes whether it were enlarged at initial 
diagnosis so that it boosted up to 60-66Gy with electron. 
Secondly, boost to the primary target volume that had 
minimal intracranial extension or skull base involvement 
so that optic chiasm shielding was introduced at 50Gy 
and delivered dose up to 66-70Gy. However there were 
situation where primary diseases was so extensive either in 
the form of intracranial extension or surrounding structure 
involvement that we have to reduced our target volume so 
that normal structure tolerance dose were not exceeded 
and introduced phase 4 or in some case up to phase 5 
that focused only primary target volume or epicenter of 
tumor. The lower neck nodes were treated to 50-66Gy with 
either a direct anterior field or anterior-posterior opposed 
fields junctioned to the superior lateral fields with midline 
shielding to protect the spinal cord once its tolerance dose 
reached through mono-isocenter technique. 
 In patients who had intracranial extension or tumor 
involving the orbit or frontal sinus split field technique 
were used. Tumor with anterior extension to the nasal 
cavity anterior field was introduced after phase 2. PTV 4-5 
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usually covered by 3-4 field (oblique, anterior, lateral).
Chemotherapy
 All patients in the study group received chemotherapy 
either in the neo-adjuvant, concurrent or adjuvant setting. 
Chemotherapy regimen was based on cisplatin and 
fluoropyrimidine (5-FU).
Methods
 Medical charts were reviewed to obtain demographic 
and treatment information. For technical purpose 
cumulative dose volume histogram (DVH) of each plan 
was evaluated to find the number of phases required to 
complete the treatment, volumes of different phases as 
well as its coverage by the 95% isodoses line. The reason 
to choose 95% isodose line for PTV coverage was as it 
represents the minimal acceptable isodose limit of the 
dose delivered to a well defined prescription point within 
the target according to ICRU report 50 recommendation. 
Dose to the critical normal structures were also noted. 
When 95% isodose line failed to cover the PTV, efforts 
were made to determine the factors responsible for it.
 Data was entered and analyzed through SPSS 
(Statistical Package for Social Sciences) version 19. 
Descriptive statistics were used to summarize data.
Results 
 In the study cohort there were 36 (80%) male and 9 
(20%) female. Median age at presentation was 41 years 
ranged from 12-84 years. No patient with T1 diseases was 
identified, 10 (22.2%) had T2 diseases while 12 (26.7%) 
and 23 (51.1%) had T3 and T4 diseases respectively. 
Majority of the patients had N2 diseases 24 (53.3%) while 
only one patient was found to have no neck node diseases. 
Most of the patients had locally advanced diseases 
at presentation especially stage IV A&B (46.7% and 
11.1%) respectively with 33.3% had diseases that extend 
intracranially at presentation (Table 1). Median radiation 
dose was 70Gy. The lowest dose in the cohort was 60Gy 
that was prescribed to a 12 years old boy according to 
accompanied pediatric protocol. Other than that 66Gy 
was the minimum prescribed dose except two cases one 
had extensive intracranial extension and tolerance limit 
to surrounding structure was reached at 64Gy other was 
planned for 70Gy but he refused for further treatment 
after 64Gy. Almost all patients received chemotherapy. 
Neo-adjuvant chemotherapy was offered to 39 (86.6%) 
who had locally advanced diseases at presentation. 
Adjuvant chemotherapy was offered to 10 patients who 
had residual diseases at the end of the treatment. Fifty-
percent of the patients completed their treatment in 4 
phases. While 37% patients were finished their treatment 
in 3 phases. However in 5 patients phase 5 were used to 
achieve prescribed doses. Planning target volume showed 
reduction in the volume as it went up from PTV 3 to PTV 
5 due to shrinkage of fields as well as volume (Table 2).
 PTV coverage by 95% isodose line was worst for PTV 
3 due to its large volume and best for PTV 5 as its only 
include the epicenter of the diseases i.e. nasopharynx. 
Radiation dose to the critical surrounding structure 
were also within tolerance limit. No effort had been 
made to limit the dose of parotid glands as majority 
Table 1. Characteristics of Patients with Nasopharyngeal 
Carcinoma
Characteristic No. of patients (%)
Gender Male 36 (80%)
 Female 9 (20%)
Age Median (range) years 41 (12-84)
T category T1 0   (0%)
 T2 10 (22.2%)
 T3 12 (26.7%)
 T4 23 (51.1%)
N Category N0 1   (2.2%)
 N1 15 (33.3%)
 N2 24 (53.3%)
 N3 5 (11.1%)
Stage I 0   (0%)
 II 5 (11.1%)
 III 14 (31.1%)
 IV A 21 (46.7%)
 IV B 5 (11.1%)
Intracranial Extension  15/45 (33.3%)
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Table 2. Specifications of Radiation Treatment
Treatment specifications No. of patients (%)
Radiation dose median (Range) 70 Gy (60-74 Gy)
Chemotherapy                                                               N=45    (%)
 Neo-adjuvant 39 (86.6%)
 Concurrent 43 (95.5%)
 Adjuvant 10 (22.2%)
Radiation therapy phases 3 17 (37.8%)
 4 23 (51.1%)
 5 5 (11.1%)
Planning Target Volume (PTV)                           Mean (Range)in cm3
 3 247.8 (50-644.3)
 4 173.8 (26.5-345.1)
 5  119.6 (18.9-246.1)
PTV coverage by 95% isodose line                     Observed/total (%)
 3 29/39 (74.4%)
 4 24/28 (85.7%)
 5 5/5 (100%)
Radiation dose to spinal cord: Mean (range) 44.2 (42-46.4 Gy)
Radiation dose to optic chiasm: Mean (range) 52 (47.5-56.5 Gy)
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Table 3. Percent of Cases with PTV Undercoverage by 
95% Isodoses by T Stage
PTV T stage
 T1 (%)     T2 (%)     T3 (%)     T4 (%)     Total (%)
PTV 3 - 2 (20) 2 (20) 6 (60) 10 (100)
PTV 4 - - 1 (25) 3 (75) 4 (100)
Table 4. Distribution of PTV Under Coverage by 95% 
Isodose Line According to the Intracranial Extension 
and Tumor Volume
PTV Intracranial extension
 Yes (%)           No (%) Total (%)
PTV 3 5 (50) 5 (50) 10 (100)
TV 4 3 (75%) 1 (25) 4 (100)
PTV Tumor volume
 <200cm3 (%)         >200cm3 (%) Total (%)
PTV3 3 (30) 7   (70) 10 (100)
PTV4 0 4 (100) 4 (100)
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of the patients presented with advanced diseases with 
parapharyngeal involvement and enlarged bilateral 
cervical lymphadenopathy (Table 3).
 PTV under coverage by 95% isodose line were 
stratified with T stage, volume of PTV and found that it 
was progressively deteriorated as the T stage got advanced 
especially with intracranial extension and when PTV 
volume exceed 200 cm3 (Table 4).
Discussion
Nasopharyngeal carcinoma posed a unique challenge 
to the radiation oncologist for its management due to 
its crucial location, infiltrative spread pattern, advanced 
stage at presentation and surrounding critical normal 
structure. Local control remains a major problem for many 
patients and it is directly related to the dose delivered to 
the target volume (Teo et al., 2006). Although classical 
Ho’s 2D technique for nasopharyngeal cancer had been 
traditionally practiced for a long time but attempts of dose 
escalation and introduction of CT scan based planning 
system led to the realization of 2D technique limitation. 
This was addressed by Waldron et al. (2003) in his paper 
in which he transferred the 2D fields of the treated patients 
to 3D planning system and then it was evaluated in term of 
53, 90 and 95% isodoses line coverage of GTV and area 
of under coverage was also determined. The GTV was 
covered by the 50, 90 and 95% isodoses lines of all phases 
of the multiphase plan in only 50, 20 and 9% of patients 
respectively. The area of under coverage was found to be 
superior (base of skull) followed by posterior/superior or 
posterior (brainstem/spinal cord) (Waldron et al., 2003). 
Chau et al. (2001) also did the 3D dosimetric evaluation 
of the conventional radiotherapy technique found that 
problem of geographical miss was less significant in 
early stage diseases and the area with highest potential 
for missing include edge of shielding, blocks and field 
border (Chau et al., 2001). One of the interesting and 
important differences between 2D and 3D techniques is 
the pattern of failure 2D results in loco regional failure 
while three dimensional results in failure at distant site 
due to improved local control (Teo et al., 2004).
Three dimensional radiotherapy is the current standard 
of practice, it provides improvement in dose distribution 
conformity to the tumor volume while concomitantly 
reducing dose to the surrounding normal structure, 
generally it is based on CT scan however others imaging 
modalities like MRI, PET is also emerging for planning 
purpose (Nishioka et al., 2002). CT scan based voluming 
although provide good information of tumor extent but 
due to less sensitivity for soft tissue sometimes result in 
over estimation leading to large volume that is difficult to 
cover with high dose due to surrounding normal structure 
(Rasch et al., 2010). 
Although 3D-CRT results in improved tumor coverage 
but it has its own limitations like planner’s expertise, 
manual iteration to achieve an optimal plan and more 
important its ability to control the radiation beam in two 
dimensions only. Also the stage and shape of the tumor 
has found to have significant influence as multidirectional 
spread lead to irregular shaped volume particularly 
concave shape that is very difficult to be looked after by 
3 dimensional radiotherapy. Studies have shown that as 
the tumor stage advances especially intracranial extension 
tumor coverage become compromised as we have also 
observed in our study as well, being a developing country 
majority of the patients presented with advanced stage 
due to lack of awareness and scarce medical facilities 
as shown in our previous study (Abbasi et al., 2011). 
Secondly due to its unique location advanced stage at 
presentation is common as evident by study from India 
by Sharma et al. (2011) who reported that almost 71.5% 
of patients had advanced diseases at presentation and 
25% had intracranial extension (Sharma et al., 2011). 
Moreover small separation between critical structures 
and target also create trouble for tumor coverage. All 
these factors were identified by Lee et al. (2002). To 
address these challenges more advanced technology were 
developed like intensity modulated radiotherapy (IMRT) 
and compared it with 3DCRT. Various studies both case 
series as well as randomized trials have been published on 
its merits and demerits (Bhide et al., 2012). The potential 
of IMRT for better tumor coverage especially for concave 
tumor volume has been demonstrated in nasopharyngeal 
cancer patients (Tribius et al., 2011). In a series of 23 
patients of nasopharyngeal cancer treated with IMRT, 
Hunt et al. (2001) compared IMRT treatment plan with 
2DRT and 3DRT. They found that IMRT resulted in an 
escalation of the mean target (PTV) dose to 77.3Gy as 
compared to 67.9Gy from conventional plan and 74.6Gy 
from 3D plan. Also produced improved dose coverage of 
the skull base and cervical nodes and a significant dose 
reduction to spinal cord, temporal lobe and mandible. 
Reduction of spinal cord dose from 49Gy (2D) to 44Gy 
and 34.5Gy from 3D and IMRT respectively. Moreover 
volume of mandible and temporal lobes getting more 
than 60Gy also decreased by 10-15% with IMRT (Hunt 
et al., 2001). This finding were confirmed by Chang et al. 
(2011) who compared two different techniques of IMRT 
(fixed field and serial tomotherapy) with conventional 
3DRT in 12 patients and found that IMRT resulted in 
better CTV and GTV coverage for the primary tumor 
and neck nodes (Chung et al., 2011). Another study by 
Hsiung et al. (2002) compared the IMRT and 3D-CRT 
plan for the boost treatment of new onset nasopharyngeal 
cancer or as salvage he observed a more homogenous dose 
distribution in IMRT plan he found the mean target dose 
D05 (dose to 5% volume) was decreased from 127.9% 
with 5-fields 3D-CRT to 117.4% with 5-fields IMRT 
(p=0.001 compared with 3D-CRT) and to 112.7% with 
7-fields IMRT (p<0.001 compared with 3D-CRT). He 
also identified five anatomic factors that were associated 
with tumor coverage compromise from 3D-CRT and got 
maximum benefit with IMRT. These were >7cm vertical 
length of target, minimal distance between target and 
brainstem <0.1cm, anterior-posterior (AP) overlap of 
target and brainstem >0.6cm, maximal AP overlap of 
target and spinal cord and vertical overlap of target and eye 
(Hsiung et al., 2002). Investigator from Hong Kong also 
reviewed the literature and found better tumor coverage, 
geometric accuracy, dosimetric homogeneity and normal 
organ sparing and allows room for dose escalation in 
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locoregionally advanced nasopharyngeal cancer with 
IMRT (Teo et al., 2004).
Importance of tumor volume has been established in 
others head and neck cancer but its role in nasopharyngeal 
cancer is not cleared although studies have shown a direct 
relationship between tumor volume and outcome (Guo et 
al., 2012). According to studies tumor volume indicated 
the number of tumor clonogens that should be removed. 
An increasing tumor bulk relates to an increasing number 
of tumor clonogen requiring sterilization by higher 
radiation dose (Ogawa et al., 2013). Though nasopharynx 
tumor staging system is based on tumor extent to 
surrounding structure, several studies have shown that 
tumor volume varied substantially within the same T group 
hence effecting tumor coverage by the radiation isodoses 
therefore establishing as a prognostic significance (Zhou 
et al., 2007). We also witnessed the same observation in 
our study that if tumor volume was <200cm3 then it was 
better covered by 95% isodoses line as compared to tumor 
volume of >200cm3. 
With the realization of the limitation of the our study 
i.e. retrospective and small cohort of patients it shows the 
limitation of the standard conformal therapy to adequately 
provide coverage of the planning target volume in complex 
cases with advanced surrounding structure invasion 
especially intracranial extension and large volume. Our 
practice also evolved considerably over this period with 
incorporation of field in field and split field techniques to 
improve tumor coverage without harming adjacent normal 
structure and now incorporating IMRT system for such 
complicated cases. 
In conclusion, 3D conformal radiotherapy result in 
good tumor coverage by 95% isodose line in majority 
of nasopharyngeal cancer but struggle with its limitation 
when come across with advanced stage tumor, intracranial 
extension and large tumor volume. Therefore more 
advanced technique is required for such complex cases 
to improve outcome. 
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